IL6R and obesity due to melanocortin 4 receptor deficiency: The results of the IL‐6 receptor (IL‐6R) inhibitor tocilizumab on patients with obesity also highlight the importance of this cytokine as a key hotspot in the interaction between obesity and COVID‐19.80